By combining the biological specificity of antibodies, triggered by external light energy, and the metabolic mechanism in cells, we have created a new therapeutic method, iTAP (intelligent Targeted Antibody Phototherapy), which is our core technology.

We are conducting research and development with the aim of developing new treatment methods with superior efficacy and fewer side effects, mainly in the field of oncology.